{"id":"NCT02468232","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction","officialTitle":"A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06-15","primaryCompletion":"2019-02-08","completion":"2021-02-18","firstPosted":"2015-06-10","resultsPosted":"2023-12-08","lastUpdate":"2023-12-08"},"enrollment":225,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Heart Failure With Reduced Ejection Fraction (HF-rEF)"],"interventions":[{"type":"DRUG","name":"LCZ696","otherNames":[]},{"type":"DRUG","name":"Enalapril","otherNames":[]},{"type":"DRUG","name":"Placebo to LCZ696","otherNames":[]},{"type":"DRUG","name":"Placebo to Enalapril","otherNames":[]}],"arms":[{"label":"LCZ696","type":"EXPERIMENTAL"},{"label":"Enalapril","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was to assess the effect of LCZ696 at a target dose of 200 mg b.i.d. compared to enalapril 10 mg b.i.d., in addition to the background heart failure (HF) treatment, on delaying time to first occurrence of either cardiovascular (CV) death or HF hospitalization events in Japanese patients with stable chronic heart failure (CHF), New York Heart Association (NYHA) classes II-IV and reduced ejection fraction (left ventricular ejection fraction (LVEF) â‰¤ 35%).","primaryOutcome":{"measure":"Number of Participants Who Had CEC (Clinical Endpoint Committee) Confirmed Composite Endpoints","timeFrame":"up to 40 months","effectByArm":[{"arm":"LCZ696","deltaMin":30,"sd":null},{"arm":"Enalapril","deltaMin":28,"sd":null},{"arm":"LCZ696 (Core) OLE Epoch","deltaMin":0,"sd":null},{"arm":"Enalapril (Core) OLE Epoch","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":14},"locations":{"siteCount":49,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":64,"n":111},"commonTop":["Nasopharyngitis","Cardiac failure","Renal impairment","Hypotension","Constipation"]}}